(NASDAQ: SHC) Sotera Health Co's forecast annual revenue growth rate of 4.95% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.17%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.89%.
Sotera Health Co's revenue in 2025 is $1,106,788,000.On average, 3 Wall Street analysts forecast SHC's revenue for 2025 to be $324,866,455,092, with the lowest SHC revenue forecast at $323,810,514,216, and the highest SHC revenue forecast at $326,825,055,102. On average, 3 Wall Street analysts forecast SHC's revenue for 2026 to be $344,640,651,112, with the lowest SHC revenue forecast at $340,347,910,827, and the highest SHC revenue forecast at $347,535,121,301.
In 2027, SHC is forecast to generate $368,950,567,359 in revenue, with the lowest revenue forecast at $368,866,830,112 and the highest revenue forecast at $369,034,304,606.